who hq reports g2 prod ext tbfinancingcountryprofile
DESCRIPTION
WHO reportTRANSCRIPT
Indonesia| High TB burden | High HIV burden | High MDR-TB burden | Tuberculosis finance profile
Gross national income per capita, 2013 (USD): 3580
WHO TB planning and budgeting tool used: No
Total National TB Programme (NTP) budget, available funding and expenditureFunding by source (US$ millions)
2006 2008 2010 2012 2014 0
10
20
30
40
50
6070
Grants (exc Global Fund)
Global Fund
Loans
Government, NTP budget
Funding by line item (US$ millions)
2006 2008 2010 2012 2014 0
10
20
30
40
50
6070
Unknown
OR/Surveys/Other
PPM/PAL/ACSM/CBC
TB/HIV
MDR-TB
DOTS
Funding gap by line item (US$ millions)
2006 2008 2010 2012 2014 0
20
40
60
80
OR/Surveys/Other
PPM/PAL/ACSM/CBC
TB/HIV
MDR-TB
DOTS
Received funding (dotted line) and actual expenditure by line item (bar)(US$ millions)
2007 2008 2009 2010 2011 2012 2013 0
10
20
30
40
50
60
Unknown
OR/Surveys/Other
PPM/PAL/ACSM/CBC
TB/HIV
MDR-TB
DOTS
* ACSM: Advocacy, Communication and Social Mobilization; CBC: Community-based TB Care; PAL: Practical Approach to Lung Health; PPM: Public-Private Mix; OR: Operational Research
Average expenditure per patient
Average expenditure per notified TB patient(US$ per patient)
2008 2009 2010 2011 2012 2013 0
25
50
75
100
125
Average expenditure per patient treated for MDR-TB(US$ per patient)
2008 2009 2010 2011 2012 2013 0
5000
10000
15000
20000
25000
Use of general health services
Average length of hospital stay during treatment (days)
2006 2008 2010 2012 2014 0
5
10
15
New smear-positive
New smear-neg/extrap
First-line treatment
MDR-/XDR-TB treatment
Outpatient care during treatment (typical number of visits)
2006 2008 2010 2012 2014 0
100
200
300
400
500
600
700800
New smear-positive
New smear-neg/extrap
First-line treatment
MDR-/XDR-TB treatment
Data are as reported to WHO. GNI per capita source: World Bank Generated: February 23, 2015 Source: www.who.int/tb/data